Pigment epithelium-derived factor in lipid metabolic disorders

Biomed J. 2018 Apr;41(2):102-108. doi: 10.1016/j.bj.2018.02.004.

Abstract

Pigment epithelium-derived factor (PEDF) is a secreted glycoprotein that has anti-angiogenic, anti-proliferative, neurotrophic and immunomodulatory properties. PEDF has recently emerged as a critical metabolic regulatory protein since the discovery of its modulatory activities in the lipolytic pathway by binding to adipose triglyceride lipase (ATGL). Despite being beneficial in maintaining the homeostasis of hepatic lipid accumulation, PEDF has been uncovered an unfavorable role associated with insulin resistance. The molecular events that connect these two apparent distinct observations have been controversial and remained largely unknown. Therefore in this short review, we attempt to summarize the current findings of PEDF regarding its lipid metabolic functions and provide perspectives in identifying PEDF as a potential therapeutic target in lipid disorders.

Keywords: Adipose tissue; Adipose triglyceride lipase; Insulin resistance; Liver; Pigment epithelium-derived factor.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / metabolism
  • Animals
  • Eye Proteins / physiology*
  • Eye Proteins / therapeutic use
  • Humans
  • Insulin Resistance
  • Lipid Metabolism*
  • Liver / metabolism
  • Metabolic Diseases / drug therapy*
  • Nerve Growth Factors / physiology*
  • Nerve Growth Factors / therapeutic use
  • Serpins / physiology*
  • Serpins / therapeutic use

Substances

  • Eye Proteins
  • Nerve Growth Factors
  • Serpins
  • pigment epithelium-derived factor